AG019FWC

6106-07-6 | sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate pentahydrate

AG019FWC

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	6106-07-6
Catalog Number	AG019FWC(AGN-PC-0SYOP2)
Chemical Name	sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate pentahydrate
EC Number	200-221-4
IUPAC Name	sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;pentahydrate
InChI	InChI=1S/C15H11I4NO4.Na.5H2O/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23;;;;;;/h1-2,4-5,12,21H,3,20H2,(H,22,23);;5*1H2/q;+1;;;;;/p-1/t12-;;;;;;/m0....../s1
InChI Key	JMHCCAYJTTWMCX-QWPJCUCISA-M
MDL Number	MFCD06408007
Molecular Formula	C15H20I4NNaO9
Molecular Weight	888.9283
SMILES	[O-]C([C@H](CC1=CC(I)=C(C(I)=C1)OC2=CC(I)=C(O)C(I)=C2)N)=O.[Na+].O.O.O.O.O
UNII	9J765S329G
Synonyms	3,5,3',5'-Tetraiodothyronine, Berlthyrox, Dexnon, Eferox, Eltroxin, Eltroxine, Euthyrox, Eutirox, L Thyrox, L Thyroxin beta, L Thyroxin Henning, L Thyroxine, L Thyroxine Roche, L-3,5,3',5'-Tetraiodothyronine, L-Thyrox, L-Thyroxin beta, L-Thyroxin Henning, L-Thyroxine, L-Thyroxine Roche, Lévothyrox, Levo T, Levo-T, Levothroid, Levothyroid, Levothyroxin Deladande, Levothyroxin Delalande, Levothyroxine, Levothyroxine Sodium, Levoxine, Levoxyl, Novothyral, Novothyrox, O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine, Oroxine, Sodium Levothyroxine, Synthroid, Synthrox, T4 Thyroid Hormone, Thevier, Thyrax, Thyroid Hormone, T4, Thyroxin, Thyroxine, Tiroidine, Tiroxina Leo, Unithroid, L-Thyroxine sodium salt pentahydrate, 6106-07-6, Sodium L-thyroxine pentahydrate, Sodium levothyroxine, UNII-9J765S329G, L-Thyroxine (sodium salt pentahydrate), L-Thyroxine sodium pentahydrate, 9J765S329G, 55-03-8, 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine sodium salt, L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt, pentahydrate, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine sodium salt pentahydrate, Alanine, 3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)-, monosodium salt, pentahydrate, 25416-65-3, L-Thyroxine,sodium salt, Levothyroxine sodium salt, xoEthy(1/4)xx IUEOAAE, C15H20I4NNaO9, levothyroxine sodium pentahydrate, Sodium levothyroxine pentahydrate, CTK8G0676, DTXSID10209941, Sodium (S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoate pentahydrate, GP5241, HY-18341A, MFCD00149110, sodium levothyroxine(1-) pentahydrate, CS-1820, I994, LS-158294, FT-0603686, ST24047480, Q-201332, 3',3,5',5-Tetraiodo-L-thyronine sodium salt pentahydrate, 3,3',5,5'-Tetraiodo-L-thyronine sodium salt pentahydrate, UNII-YW8HJ0N26X component JMHCCAYJTTWMCX-QWPJCUCISA-M, L-Thyroxine sodium salt pentahydrate, >=98% (HPLC), powder, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine monosodium salt pentahydrate, (2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate sodium salt pentahydrate, 3-[4-(4-oC>>u-3,5- paragraph signthornmicroa+/-(1/2)No>>u)-3,5- paragraph signthornmicroa+/-(1/2)>>u]-L-+/-u degrees +/-Ea AAENI, L-Thyroxine sodium salt pentahydrate, gamma-irradiated, powder, BioXtra, suitable for cell culture, eltroxin, levothroid, synthroid, Berlthyrox, Latequatro, Letequatro, Levoroxine, Novothyrox, Thyronamin, Thyroxevan, Thyroxinique, Dathroid, Euthyrox, Laevoxin, Levoroxin, Levotiron, Soloxine, Thyradin, Thyrosit, Tiroidina, Tirosint, Tiroxina, Tyrosint, Unithroid, Levaxin, Leventa, Levolet, Levoxyl, Oroxine, Roxstan, Tetroid, Thevier, Tivoral, Eferox, Letter, Sodium thyroxin, Thyroxin sodium, Ro-thyroxine, L-thyroxine, Sodium thyroxine, Synthroid sodium, Thyroxine sodium, L-Thyroxine sodium, Thyradin S, Thyro-Tabs, Thyroxine sodique, Levothyroxine sodium, Sodium thyroxinate, Levothyroxinesodium, Sodium l-thyroxin, Levotiroxina sodica, Thyroxinum natricum, Levo-T, Sodium L-thyroxine, Sodium-L-thyroxine, levothyroxinnatrium-, Levothyroxin-natrium, Levo-Tiroxina Glaxo, Levothyroxine sodique, Levothyroxinum natricum, l-Thyroxine monosodium salt, Levothyroxine sodium tablets, UNII-054I36CPMN, Levothyroxine Sodium [USAN], Sodiumlevothyroxinepentahydrate, C15H11I4NO4.Na, Monosodium L-thyroxine hydrate, Levothyroxine Sodium [USAN:INN], Levotiroxina sodica [INN-Spanish], Levothyroxine sodique [INN-French], C15-H11-I4-N-O4.Na, EINECS 200-221-4, Levothyroxinum natricum [INN-Latin], CID201498, Levothyroxine sodium [USP:INN:JAN], ACN-034092, NSC 259940, C15-H10-I4-N-Na-O4.x-H2-O, B1275, 3,3',5,5'-Tetraiodo-L-thyronine, sodium salt, L(+)-Glutamic acid monosodium salt monohydrate, 99%, L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, t4, L-Tirosina, O-(4-hidroxi-3,5-diiodofenil)-3,5-diiodo-, sal de sodio (1:1), L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate,

Complexity	426
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	7
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	888.721g/mol
Formal Charge	0
Heavy Atom Count	30
Hydrogen Bond Acceptor Count	10
Hydrogen Bond Donor Count	7
Isotope Atom Count	0
Molecular Weight	888.931g/mol
Monoisotopic Mass	888.721g/mol
Rotatable Bond Count	5
Topological Polar Surface Area	101A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number